Verition Fund Management
GILD icon

Verition Fund Management’s Gilead Sciences GILD Stock Holding History

Verition Fund Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.83M Sell
20,300
-27,600
-58% -$3.86M 0.02% 844
2025
Q4 		$5.88M Sell
47,900
-22,300
-32% -$2.71M 0.02% 763
2025
Q3 		$7.79M Buy
70,200
+2,800
+4% +$318K 0.03% 706
2025
Q2 		$7.47M Buy
67,400
+23,700
+54% +$2.52M 0.03% 724
2025
Q1 		$4.9M Sell
43,700
-32,700
-43% -$3.37M 0.02% 856
2024
Q4 		$7.06M Buy
76,400
+38,100
+99% +$3.43M 0.03% 691
2024
Q3 		$3.21M Buy
38,300
+27,100
+242% +$2.07M 0.02% 1138
2024
Q2 		$768K Sell
11,200
-12,800
-53% -$854K ﹤0.01% 1823
2024
Q1 		$1.76M Buy
24,000
+10,100
+73% +$777K 0.01% 1277
2023
Q4 		$1.13M Buy
+13,900
New +$1.08M 0.01% 1115
2023
Q1 		– Sell
-18,400
Closed -$1.58M – 2301
2022
Q4 		$1.58M Hold
18,400
– – 0.02% 712
2022
Q3 		$1.14M Buy
+18,400
New +$1.16M 0.01% 1297
2022
Q2 		– Sell
-18,300
Closed -$1.09M – 2612
2022
Q1 		$1.09M Hold
18,300
– – 0.01% 1402
2021
Q4 		$1.33M Sell
18,300
-91,700
-83% -$6.32M 0.01% 1115
2021
Q3 		$7.68M Buy
+110,000
New +$7.73M 0.07% 194

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Verition Fund Management's GILD Position: Q1 2026 in Review

Verition Fund Management reduced its Gilead Sciences (GILD) stake by 90% in Q1 2026, selling an estimated $8.61M and leaving 6,709 shares worth $935K. The position accounts for 0.01% of the portfolio, ranked #1334.

Verition Fund Management first reported a position in GILD in Q3 2013 and has held it in 38 quarters since. The position peaked at $33.2M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Verition Fund Management held 6,709 shares of Gilead Sciences worth $935K as of Q1 2026.
  • Verition Fund Management sold 61,468 Gilead Sciences shares in Q1 2026, an estimated $8.61M.
  • Gilead Sciences made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #1334 holding.
  • Verition Fund Management first reported a position in Gilead Sciences in Q3 2013 and has held it in 38 quarters since.
  • Verition Fund Management's Gilead Sciences position peaked at $33.2M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.